Launch of the Rapid Microfluidic Immunoassay C-Reactive Protein Test by LumiraDx in India to Help Fight Antimicrobial Resistance

LumiraDx Healthcare Private Limited has announced the availability of a high-sensitivity C-Reactive Protein (CRP) point of care antigen test in India . The CRP test delivers results in four minutes on a tiny sample of finger-prick blood .

LumiraDx Healthcare Private Limited, a next-generation point of care diagnostics firm, has announced the availability of a high-sensitivity C-Reactive Protein (CRP) point of care antigen test in India.The point of care CRP test can be used in a variety of clinical applications to reduce unnecessary antibiotic prescribing that results in antimicrobial resistance.On the lightweight LumiraDx machine that weighs just over a kilogram, the CRP test delivers results in four minutes on a tiny sample of finger-prick blood.Studies show that point-of-care CRP testing reduces antibiotic prescribing by 23-26 percent for respiratory tract infections (RTI)1, and 22% for COPD2.

6CRP tests can effectively help to eliminate unnecessary antibiotic prescribing in primary care.1 Antimicrobial resistance has impacted India, one of the worlds most densely populated countries.According to Yogesh Singh, Chief Innovation Officer of LumiraDx, the availability of the LumiraDx CRP Point of Care Antigen Test can help to ensure that antibiotics are only given to those individuals who need them, particularly when excessive prescriptions, self-medication, and poor compliance are present.AMR is a top health problem in India, and the Government of India has taken up a national campaign to create an AMR stewardship initiative.LumiraDx has more information on the website at.1.

doi:10.1136/bmjresp-2020-0006242.e000624.Open Respir Res.2020;7(1):e000624.

Use C-Reactive Protein Analysis to Guide Antibiotic Prescription for COPD Exacerbations.N Engl J Med.2019;381(2):111-120. doi:10.1056NEJMoa1803185 3.Megha Sharma and Neelam Taneja.

2019 Feb; 149(2): 119-128.4.Indian J Med Res.2019 Feb; 149(2): 119-128.4.The World Health Organisation (WHO) has released an update on the topic.

London, 2016.6: HM Government and Wellcome Trust, London.Goossens H, Ferech M, Vander Stichele R, et al.Outpatient antibiotic use in Europe and its correlation with antibiotic resistance: a cross-national database survey.This paper has been published by.

.
.
.
.